Arch Capital Group Ltd. $ACGL Shares Acquired by Robeco Institutional Asset Management B.V.

Robeco Institutional Asset Management B.V. grew its stake in Arch Capital Group Ltd. (NASDAQ:ACGL) by 50.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,548,042 shares of the insurance provider’s stock after purchasing an additional 518,527 shares during the period. Robeco Institutional Asset Management B.V.’s holdings in Arch Capital Group were worth $148,488,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of the stock. WCM Investment Management LLC increased its holdings in shares of Arch Capital Group by 1.3% in the third quarter. WCM Investment Management LLC now owns 13,525,402 shares of the insurance provider’s stock valued at $1,214,987,000 after purchasing an additional 171,693 shares during the period. JPMorgan Chase & Co. boosted its stake in shares of Arch Capital Group by 4.6% in the third quarter. JPMorgan Chase & Co. now owns 8,190,927 shares of the insurance provider’s stock valued at $743,168,000 after buying an additional 360,626 shares in the last quarter. First Trust Advisors LP boosted its stake in shares of Arch Capital Group by 409.5% in the third quarter. First Trust Advisors LP now owns 2,835,648 shares of the insurance provider’s stock valued at $257,278,000 after buying an additional 2,279,147 shares in the last quarter. UBS Group AG boosted its stake in shares of Arch Capital Group by 56.4% in the third quarter. UBS Group AG now owns 2,738,518 shares of the insurance provider’s stock valued at $248,466,000 after buying an additional 987,398 shares in the last quarter. Finally, Marshfield Associates boosted its stake in shares of Arch Capital Group by 5.5% in the third quarter. Marshfield Associates now owns 2,724,635 shares of the insurance provider’s stock valued at $247,206,000 after buying an additional 141,223 shares in the last quarter. Institutional investors and hedge funds own 89.07% of the company’s stock.

Arch Capital Group Price Performance

ACGL opened at $95.97 on Monday. The business’s fifty day moving average is $96.93 and its two-hundred day moving average is $93.71. The company has a debt-to-equity ratio of 0.13, a quick ratio of 0.53 and a current ratio of 0.53. The company has a market cap of $34.19 billion, a price-to-earnings ratio of 8.26, a PEG ratio of 3.92 and a beta of 0.41. Arch Capital Group Ltd. has a one year low of $82.44 and a one year high of $103.39.

Arch Capital Group (NASDAQ:ACGL) last posted its earnings results on Monday, February 9th. The insurance provider reported $2.98 EPS for the quarter, topping analysts’ consensus estimates of $2.34 by $0.64. The company had revenue of $4.93 billion for the quarter, compared to the consensus estimate of $3.94 billion. Arch Capital Group had a return on equity of 16.73% and a net margin of 22.07%.During the same period in the previous year, the business earned $2.26 earnings per share. Analysts anticipate that Arch Capital Group Ltd. will post 8.42 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of research firms recently weighed in on ACGL. Evercore set a $100.00 price target on Arch Capital Group and gave the company an “in-line” rating in a research note on Wednesday, January 7th. JPMorgan Chase & Co. lifted their price target on Arch Capital Group from $111.00 to $117.00 and gave the company a “neutral” rating in a research note on Wednesday, January 7th. Citigroup restated a “buy” rating and issued a $120.00 price target (up from $113.00) on shares of Arch Capital Group in a research note on Friday, February 13th. Mizuho lifted their price target on Arch Capital Group from $95.00 to $102.00 and gave the company a “neutral” rating in a research note on Thursday, February 12th. Finally, Morgan Stanley set a $125.00 price target on Arch Capital Group in a research note on Friday, January 16th. Nine equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $109.40.

Insider Transactions at Arch Capital Group

In other Arch Capital Group news, insider David Gansberg sold 5,907 shares of the business’s stock in a transaction on Tuesday, March 10th. The stock was sold at an average price of $96.37, for a total transaction of $569,257.59. Following the sale, the insider directly owned 336,559 shares in the company, valued at approximately $32,434,190.83. The trade was a 1.72% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Nicolas Papadopoulo sold 21,930 shares of the business’s stock in a transaction on Tuesday, March 10th. The stock was sold at an average price of $96.31, for a total value of $2,112,078.30. Following the sale, the chief executive officer owned 871,594 shares in the company, valued at approximately $83,943,218.14. The trade was a 2.45% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 78,267 shares of company stock valued at $7,291,637 in the last three months. 3.30% of the stock is owned by company insiders.

Arch Capital Group Profile

Arch Capital Group Ltd. (NASDAQ: ACGL) is a Bermuda-based insurance and reinsurance holding company that underwrites a broad range of property and casualty, mortgage, and specialty risk products. The company operates through a group of underwriting subsidiaries and platforms to provide insurance, reinsurance and related risk solutions tailored to commercial, institutional and individual clients.

Arch’s product mix includes treaty and facultative reinsurance, primary casualty and property insurance, mortgage insurance and other specialty lines.